New analysis recasts benefits of treatment in relation to day-to-day impacts on patients’ lives.
Next-gen Alzheimer’s drugs extend independent living by months (Links to an external site)

New analysis recasts benefits of treatment in relation to day-to-day impacts on patients’ lives.
More than 6 million people in the U.S. and millions more around the world have Alzheimer’s, the most common form of dementia.